|
Company
Roster
|
Total
Insiders : |
25 |
|
|
Total
Direct Shares :
|
602,313 |
|
Total
Indirect Shares :
|
692,152 |
|
%
Held by Insiders:
|
0.8% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Winquist Raymond |
Head, Translational Research |
2017-08-18 |
1,000 |
2017-08-18 |
0 |
Von Seggern Christopher |
Chief Commercial Officer |
2021-12-06 |
4,000 |
2021-12-06 |
0 |
Tarnow Michael M |
Director |
2021-05-18 |
77,942 |
2014-11-09 |
0 |
Stein Evan A. |
Director |
2014-11-09 |
0 |
2015-04-30 |
4,172 |
Scheller Richard H |
Director |
2017-08-10 |
7,000 |
2017-08-10 |
0 |
Robin Sherrington |
|
2024-03-07 |
8,398 |
2015-08-18 |
0 |
Pimstone Simon N. |
|
2023-06-01 |
6,000 |
2020-06-01 |
16,460 |
Patou Gary |
|
2023-12-13 |
23,573 |
2023-12-14 |
4,902 |
Mx Associates, Llp |
10% Owner |
2014-12-31 |
0 |
2014-11-09 |
0 |
Mortimer Ian |
|
2023-05-24 |
31,302 |
2023-05-24 |
14,300 |
Lampert Mark N |
10% Owner |
2018-03-27 |
59,464 |
2017-06-06 |
0 |
Kenney Christopher John |
Chief Medical Officer |
2023-03-24 |
0 |
2022-01-21 |
0 |
Holler Frank A |
Director |
2021-05-27 |
143,653 |
2021-05-27 |
1,184 |
Hayden Michael R |
Director |
2021-05-18 |
116,206 |
2021-05-18 |
206,479 |
Graham Dawn |
|
2023-08-24 |
25,000 |
2017-08-14 |
0 |
Goldberg Y. Paul |
VP of Clinical Development |
2015-09-24 |
6,000 |
2015-08-18 |
0 |
Garofalo Elizabeth A. |
|
2024-03-08 |
0 |
2024-03-08 |
0 |
Gannon Steven |
|
2024-03-07 |
2,000 |
2017-08-11 |
0 |
Evans Johnston L |
Director |
2014-11-09 |
0 |
2014-11-09 |
444,655 |
Empfield James R. |
EVP, Drug Discovery |
2022-08-12 |
10,000 |
2017-08-15 |
0 |
Corraini Karen G. |
|
|
0 |
|
0 |
Cohen Charles J. |
VP, Biology |
2018-12-11 |
6,550 |
2018-02-12 |
0 |
Azab Mohammad |
|
2023-12-19 |
74,225 |
2015-01-08 |
0 |
Aycardi-Fonseca Ernesto |
|
|
0 |
|
0 |
Aulin Sherry |
Chief Financial Officer |
2022-09-02 |
0 |
2022-09-02 |
0 |
|